Quick Answer
Garlic Cognition Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: The risk of bias of ten randomized controlled trials (RCTs) included in the meta-analysis was assessed using the Cochrane guidelines.
Key Takeaways
- 01The risk of bias of ten randomized controlled trials (RCTs) included in the meta-analysis was assessed using the Cochrane guidelines. [Deshmukh S (2025)]
- 02Result A total of 44 studies was included in the systematic review, and ten RCTs involving 524 participants were included in the meta-analysis. [Deshmukh S (2025)]
- 03Conclusion This systematic review shows that although Ayurvedic interventions do not achieve significant BP reductions versus conventional treatments, they may provide clinical benefits with good safety. [Deshmukh S (2025)]
- 04Background Essential hypertension (EH) is a major contributor to cardiovascular morbidity and mortality that has become a public health challenge owing to poor control and adherence. [Deshmukh S (2025)]
The current Migaku evidence database contains 2 reusable source documents for Garlic Cognition Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts.
- The risk of bias of ten randomized controlled trials (RCTs) included in the meta-analysis was assessed using the Cochrane guidelines. [Deshmukh S (2025); evidence level 1]
- Result A total of 44 studies was included in the systematic review, and ten RCTs involving 524 participants were included in the meta-analysis. [Deshmukh S (2025); evidence level 1]
- Conclusion This systematic review shows that although Ayurvedic interventions do not achieve significant BP reductions versus conventional treatments, they may provide clinical benefits with good safety. [Deshmukh S (2025); evidence level 1]
- Background Essential hypertension (EH) is a major contributor to cardiovascular morbidity and mortality that has become a public health challenge owing to poor control and adherence. [Deshmukh S (2025); evidence level 1]
- These changes likely contribute to cognitive decline, sensorimotor impairments and increased vulnerability to neurodegenerative disorders (). [Mony Tamanna (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources